Senior insider sale
EVP & Chief Financial Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$31.1K
3.72K shares
What this filing means
O'BYRNE JASON plans to sell 3.72K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $31.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2026ACC: 0001959173-26-001442
Officer· EVP & Chief Financial Officer
Since Feb 2026
3.72K
Shares to sell
$31.1K
Approx. market value
1.63K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/23/2026
1.63KTotal acquired1.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2026 | Restricted Stock Vesting Compensation | 1.63K | — |
| Total | 1.63K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.09K
Market value
$15.6K
2/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.63K
Market value
$15.6K
2/24/2026
Total
Units
3.72K
Value
$31.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/23/2026 | 2.09K | $15.6K | — | Completed |
| Planned — Approximate Date | ||||
2/24/2026 | 1.63K | $15.6K | NASDAQ | Planned |
| Total | 3.72K | $31.1K | ||